Systems-based approaches to probing metabolic variation within the Mycobacterium tuberculosis complex

Area of Science:

• Microbiology
• Systems Biology
• Metabolic Engineering

Background:

• The Mycobacterium tuberculosis complex encompasses human and bovine strains, including Mycobacterium tuberculosis, Mycobacterium bovis, and the BCG vaccine strain.
• Distinct differences in virulence and metabolism exist between these strains, yet the role of metabolic variations in pathogenicity remains unclear.
• While systems biology has explored M. tuberculosis metabolism, comparative metabolic studies across strains are lacking.

Purpose of the Study:

• To construct and analyze genome-scale metabolic networks for M. bovis and M. bovis BCG.
• To compare these networks with M. tuberculosis to predict substrate utilization, gene essentiality, and growth rates.
• To identify discrepancies between in silico predictions and in vitro data to uncover novel metabolic insights.

Main Methods:

• Construction of genome-scale metabolic networks for M. bovis, M. bovis BCG, and M. tuberculosis.
• Interrogation of metabolic networks to predict substrate utilization, gene essentiality, and growth rates.
• Validation of model predictions against high-throughput phenotype and gene essentiality data, supplemented by experimental studies.

Main Results:

• The metabolic models accurately predicted 87-88% of phenotype data and 75-76% of gene essentiality data.
• In silico predicted growth rates closely matched experimentally measured rates.
• Discrepancies between model predictions and experimental data highlighted gaps in current metabolic knowledge, particularly regarding reduced metabolic capability in bovine strains.

Conclusions:

• Genome-scale metabolic networks are valuable tools for simulating the physiology of M. tuberculosis complex strains.
• The study identified novel insights into mycobacterial metabolism, indicating that reduced metabolic capability in bovine strains is not fully explained by current genetic or enzymatic knowledge.
• These findings underscore the utility of in silico metabolic modeling for guiding future experimental research in tuberculosis.